RxDoctor Payments Data

Erin Thomas

Family · Kingsport, TNNPI 1780919696

Payments from drug & device makers

$9,603in general payments, 2019–2025

Across 528 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Amgen$789
  • GSK$759
  • Regeneron Healthcare Solutions, Inc.$741
  • Takeda Pharmaceuticals U.S.A., Inc.$621
  • Sanofi$583
  • plus $5K from 48 others

What the payments were for

  • Food & beverage$9,21696%
  • Education$3874%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,603 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$15,425
Epinephrine12$2,378
Albuterol Sulfate HfaAlbuterol Sulfate24$499
Montelukast Sodium23$279
Azelastine Hcl14$248
Fluticasone Propionate13$153
Levocetirizine Dihydrochloride11$107

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$759$15,42518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →